Project description
Simple urine test to detect prostate cancer early
In Europe, prostate cancer is the most frequently diagnosed cancer among men. Despite the significant public health burden, late detection of advanced prostate cancer remains a major issue. The need for population-based prostate cancer screening programmes is growing. The EU-funded PROSTATOR project is developing a reliable urine test for the early diagnosis of prostate cancer that does not require unnecessary biopsies. The test will indicate which patients will need to undergo a biopsy to determine the type and the grade of the prostate tumour. The project will validate its first results on a large sample of 900 urine tests. In addition to the biomarkers quantified by commercialised urine tests, the project has identified three new biomarkers in all grades of tumours.
Fields of science
Call for proposal
ERC-2019-PoC
See other projects for this call
Funding Scheme
ERC-POC-LS - ERC Proof of Concept Lump Sum Pilot
Host institution
75231 Paris
France
Beneficiaries (1)
75231 Paris